Tags
Results for: Fralin Biomedical Research Institute Cancer Research Group
-
Article ItemFralin Biomedical Research Institute at VTC: Growth of an innovator , article
Since its founding in 2010, the research institute has become a focal point for biomedical research across Virginia Tech. It now has more than 450 faculty, staff, and students in Roanoke and Washington, D.C., supporting research fueled by $173.7 million in external grants.
Date: Aug 29, 2023 -
Article ItemVirginia Tech outlines ambitious strategy to spearhead cancer research and elevate university's global standing , article
The university is mustering its scientists and engineers behind a new strategy to help families who are struggling with cancer, a disease that occurs in almost 2 million people and claims more than 600,000 lives annually in the United States.
Date: Aug 29, 2023 -
Article ItemFralin Biomedical Research Institute spinoff Cairina Inc. translates science into improved cancer treatments , article
The company recently received support from Virginia Tech Intellectual Properties to help commercialize better tools for surgeons and oncologists.
Date: Jul 17, 2023 -
Article ItemCommon challenge, different strategies: Virginia Tech Cancer Research Alliance gathers broad mix of researchers and clinicians , article
The second annual Virginia Tech Cancer Research Alliance retreat, hosted this year on the Children’s National Research & Innovation Campus, brought together scientists and physicians on the leading edge of developing innovative therapy types, fresh biological targets, and new technologies to take on cancer.
Date: Jun 21, 2023 -
Article Item‘We have a very rich resource here’ , article
Scientist Jia-Ray Yu and collaborators tackle pediatric brain cancer in Fralin Biomedical Research Institute’s growing presence in the greater Washington, D.C., metro area.
Date: Jun 20, 2023 -
Article ItemFralin Biomedical Research Institute scientist to chair premier cancer conference , article
Jennifer Munson, a biomedical engineer and cancer researcher, was elected by her peers to co-chair the Physical Science of Cancer Gordon Research Conference in Galveston, Texas, Feb. 5 to 10
Date: Feb 03, 2023 -
Article ItemNew cancer biologist targets ‘Achilles heel’ in deadly brain cancers , article
Cancer biologist Kathleen Mulvaney joins the faculty of the Fralin Biomedical Research Institute at VTC on Oct. 1. Her lab will be in Washington, D.C., on the Children’s National Research & Innovation Campus as part of a partnership between Virginia Tech and Children’s National.
Date: Sep 27, 2022 -
Article Item11th season of the Fralin Biomedical Research Institute’s Pioneers in Biomedical Research Seminar Series launches Sept. 16 , article
The full slate features 29 experts sharing leading discoveries in cardiovascular science, cancer research, neuroscience, biomedical imaging, addiction, and health behaviors.
Date: Sep 12, 2022 -
Article ItemFralin Biomedical Research Institute expands Summer Undergraduate Research Fellowship program , article
More than 30 undergraduate and high school students worked behind the curtain of biomedical research this summer at the Fralin Biomedical Research Institute at VTC.
Date: Aug 16, 2022 -
Article ItemNew study may inform chemotherapy approaches for breast cancer , article
In a first-of-its-kind finding, Virginia Tech researchers have found platinum-based chemotherapy drugs may activate a breast cancer patient’s lymphatic system and affect how tumor cells spread. But the drugs might be made more effective if the changes to the lymphatic system can be blocked or even reversed by an additional therapy.
Date: Aug 08, 2022 -
Article ItemVirginia Tech researcher’s 3D model of brain tumor environment could aid personalized treatment , article
Scientists have developed a novel 3D tissue-engineered model of the glioblastoma tumor microenvironment that can be used to learn why the tumors return and what treatments will be most effective at eradicating them – right down to a patient-specific level.
Date: Aug 02, 2022 -
Article ItemCancer Research Alliance forges new collaborations, strengthens research programs at inaugural retreat , article
More than 100 cancer researchers from across Virginia Tech recently met at the first Cancer Research Alliance retreat hosted by the Fralin Biomedical Research Institute at VTC.
Date: Apr 04, 2022 -
Article ItemSamy Lamouille recognized as Research Mentor of the Year at Virginia Tech Carilion School of Medicine , article
Students repeatedly describe Lamouille as a mentor who empowers them to independently seek answers to research questions. He will receive the award at this year’s Medical Student Research Symposium, which is set for March 25 beginning at noon at the school.
Date: Mar 22, 2022 -
Article ItemVirginia Tech Cancer Research Alliance to host inaugural retreat for researchers , article
During the first Virginia Tech Cancer Research Alliance Retreat on March 18, 2022, alliance members will share their research, forge new collaborations, and learn from keynote speakers spanning veterinary and human oncology, and biomedical cancer research.
Date: Mar 11, 2022 -
Article ItemMedical student researches elusive path to brain cancer treatment at the Fralin Biomedical Research Institute at VTC , article
Natalia Sutherland, a fourth-year student at the Virginia Tech Carilion School of Medicine, has spent three years searching for a way to increase the effectiveness of treatment for the most common and aggressive form of primary brain cancer in adults: glioblastoma multiforme.
Date: Mar 07, 2022 -
Article ItemFralin Biomedical Research Institute at VTC researcher is Virginia Tech’s first NIH Outstanding Investigator Award recipient , article
Robert Gourdie, the Commonwealth Research Commercialization Fund Eminent Scholar in Heart Reparative Medicine Research and director of the Fralin Biomedical Research Institute Center for Vascular and Heart Research, received a $6.4 million R35 grant from the National Heart, Lung, and Blood Institute.
Date: Mar 03, 2022 -
Article ItemRare disease research gives families hope, ‘vital’ to advancing medicine , article
Rare diseases afflict 300 million people worldwide. Fralin Biomedical Research Institute at VTC researchers are bridging a gap in scientific knowledge by studying some of the diseases that together add up to a formidable public health challenge. Feb. 28 marks the 14th international Rare Disease Day.
Date: Feb 28, 2022 -
Article ItemScientists at Fralin Biomedical Research Institute develop new strategy for brain cancer treatment , article
In a new study published in Oncogenesis, Zhi Sheng and Rob Gourdie of the Fralin Biomedical Research Institute at VTC describe how two protein-targeting drugs – when combined with chemotherapy – yield synergistic cytotoxicity to treatment-resistant glioblastoma.
Date: Jan 13, 2022 -
Article ItemFralin Biomedical Research Institute biotech spin-out raises additional $305,000 in investments , article
With this wave of new grants and investments, Acomhal Research Inc. is nearing a million dollars in total funding toward development of a new therapeutic to fight drug-resistant cancers such as glioblastoma multiforme and metastatic disease including triple negative breast cancer.
Date: Dec 20, 2021 -
Article ItemNature, Fralin Biomedical Research Institute at VTC host international Glial Biology in Medicine Conference , article
The virtual conference, which took place Oct. 25–26, featured talks on how glial cells develop, age, adapt to injury or disease, and are involved in learning and memory.
Date: Oct 27, 2021
Page 1 of 2 | 26 Results